
Clinical Approach to Vitiligo and Emerging Therapies
This session will review the clinical presentation of vitiligo and when to consider the use of systemic agents. The associated autoimmune, physical, and psychological co-morbidities will be reviewed. The clinical evidence for the use of JAK inhibition, such as topical JAK inhibitors, will be discussed.




